Our People

Ludwig Cancer Research is a community of the world's leading scientists, all pursuing innovative ways to prevent and control cancer. The Ludwig Institute for Cancer Research has an expansive research presence through its branches and collaborative laboratories around the world. In addition, the Ludwig Centers are scientific partners operating independently at six elite U.S. institutions. Learn more.

Gareth L. Bond, Ludwig Institute for Cancer Research, Oxford, UK
Genomics, Tumor biology
Joan Brugge, Ludwig Center at Dana-Farber/Harvard
Cell biology, Tumor biology
Anamaria A. Camargo, Ludwig Cancer Research, Sao Paulo
Genomics, Tumor biology
Immunology, Therapeutics
Don W. Cleveland, Ludwig Institute for Cancer Research, San Diego
Cell division, Neuroscience
Stefan Constantinescu, Ludwig Institute for Cancer Research, Brussels
Signaling, Tumor biology
Sarah De Val, Ludwig Institute for Cancer Research, Oxford, UK
Tumor biology
Therapeutics, Signaling
Matthias Ernst, Ludwig Cancer Research, Melbourne
Signaling, Tumor biology
Ingvar Ferby, Ludwig Institute for Cancer Research, Uppsala, Sweden
Signaling, Tumor biology
Signaling, Tumor biology
Stem cells, Tumor biology
Signaling, Immunology
Joan Heath, Ludwig Cancer Research
Tumor biology
Paraskevi Heldin, Ludwig Institute for Cancer Research, Uppsala, Sweden
Signaling
Carl-Henrik Heldin, Ludwig Institute for Cancer Research, Uppsala, Sweden
Signaling, Tumor biology
Johan Holmberg, Ludwig Institute for Cancer Research, Stockholm
Stem cells, Tumor biology
Richard D. Kolodner, Ludwig Institute for Cancer Research, San Diego
Cell division, Tumor biology
Skirmantas Kriaucionis, Ludwig Institute for Cancer Research, Oxford, UK
Genomics, Molecular biology
Johan Lennartsson, Ludwig Institute for Cancer Research, Uppsala, Sweden
Signaling
Xin Lu, Ludwig Institute for Cancer Research, Oxford, UK
Tumor biology
Paul S. Mischel, Ludwig Institute for Cancer Research, San Diego
Signaling, Tumor biology
Aristidis Moustakas, Ludwig Institute for Cancer Research, Uppsala, Sweden
Tumor biology, Signaling
Jonas Muhr, Ludwig Institute for Cancer Research, Stockholm
Stem cells, Neuroscience
Sebastian Nijman, Ludwig Cancer Research Oxford
Cell biology, Signaling, Therapeutics
Karen Oegema, Ludwig Institute for Cancer Research, San Diego
Cell division, Genomics
Pär Olsson, Ludwig Institute for Cancer Research
Intellectual property
Thomas Perlmann, Ludwig Institute for Cancer Research, Stockholm
Neuroscience, Stem cells
Peter Ratcliffe, Ludwig Institute for Cancer Research, Oxford, UK
Signaling, Tumor biology
Bing Ren, Ludwig Institute for Cancer Research, San Diego
Genomics, Stem cells
Tumor biology, Neuroscience
Andrew Scott, Ludwig Institute for Cancer Research, Melbourne
Signaling, Therapeutics
Andrew Shiau, Ludwig Institute for Cancer Research, San Diego
Small-molecule discovery
Nicolas van Baren, Ludwig Institute for Cancer Research, Brussels
Clinical trials, Immunology
Benoît J. Van den Eynde, Ludwig Institute for Cancer Research, Brussels
Immunology, Tumor biology
Ralph Venhaus, Ludwig Institute for Cancer Research
Clinical trials
Clinical trials, Tumor biology
Immunology, Clinical trials